<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns:mv="http://macVmlSchemaUri" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta name=Title content=APE>
<meta name=Keywords content="">
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="7endocrino_archivos/filelist.xml">
<title>APE</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Santi Ibañez Caturla</o:Author>
  <o:LastAuthor>Santi Ibañez Caturla</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>3392</o:TotalTime>
  <o:LastPrinted>2013-06-23T14:54:00Z</o:LastPrinted>
  <o:Created>2014-01-31T16:11:00Z</o:Created>
  <o:LastSaved>2014-01-31T18:11:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>2695</o:Words>
  <o:Characters>14824</o:Characters>
  <o:Lines>123</o:Lines>
  <o:Paragraphs>34</o:Paragraphs>
  <o:CharactersWithSpaces>17485</o:CharactersWithSpaces>
  <o:Version>14.0</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="7endocrino_archivos/themedata.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>ES-TRAD</w:LidThemeOther>
  <w:LidThemeAsian>JA</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="276">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Courier New";
	panose-1:2 7 3 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	mso-font-charset:78;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:"MS Mincho";
	mso-font-charset:78;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073743103 0 0 415 0;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 1 Car";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:0pt;
	font-weight:normal;}
h2
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 2 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:13.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-weight:normal;}
h3
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 3 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;
	font-weight:normal;}
h4
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 4 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:12.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-weight:normal;
	font-style:italic;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Encabezado Car";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 212.6pt right 425.2pt;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Pie de p\00E1gina Car";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 212.6pt right 425.2pt;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3, li.MsoList3, div.MsoList3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4, li.MsoList4, div.MsoList4
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Texto de cuerpo Car";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
a:link, span.MsoHyperlink
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.Ttulo1Car
	{mso-style-name:"T\00EDtulo 1 Car";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 1";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo2Car
	{mso-style-name:"T\00EDtulo 2 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 2";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo3Car
	{mso-style-name:"T\00EDtulo 3 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 3";
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;}
span.Ttulo4Car
	{mso-style-name:"T\00EDtulo 4 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 4";
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-style:italic;}
span.EncabezadoCar
	{mso-style-name:"Encabezado Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Encabezado;}
span.PiedepginaCar
	{mso-style-name:"Pie de p\00E1gina Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Pie de p\00E1gina";}
span.TextodecuerpoCar
	{mso-style-name:"Texto de cuerpo Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Texto de cuerpo";}
span.apple-converted-space
	{mso-style-name:apple-converted-space;
	mso-style-unhide:no;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@page WordSection1
	{size:595.0pt 842.0pt;
	margin:36.0pt 36.0pt 36.0pt 36.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:12.3pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
@list l0
	{mso-list-id:202789493;
	mso-list-type:hybrid;
	mso-list-template-ids:1416144070 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:226041271;
	mso-list-type:hybrid;
	mso-list-template-ids:1604381164 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:235480126;
	mso-list-type:hybrid;
	mso-list-template-ids:1272054964 76576916 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:295261776;
	mso-list-type:hybrid;
	mso-list-template-ids:-477212652 76576916 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4
	{mso-list-id:480775170;
	mso-list-type:hybrid;
	mso-list-template-ids:-871840180 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5
	{mso-list-id:572594075;
	mso-list-type:hybrid;
	mso-list-template-ids:361500182 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6
	{mso-list-id:639000924;
	mso-list-type:hybrid;
	mso-list-template-ids:-2140401528 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l6:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l6:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l6:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7
	{mso-list-id:845633606;
	mso-list-type:hybrid;
	mso-list-template-ids:-1571882896 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8
	{mso-list-id:878662725;
	mso-list-type:hybrid;
	mso-list-template-ids:424701584 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l8:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l8:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l8:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l9
	{mso-list-id:1040399607;
	mso-list-type:hybrid;
	mso-list-template-ids:1007332440 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10
	{mso-list-id:1054236720;
	mso-list-type:hybrid;
	mso-list-template-ids:-774610160 76576916 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11
	{mso-list-id:1201823969;
	mso-list-type:hybrid;
	mso-list-template-ids:-1689888288 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l12
	{mso-list-id:1387532721;
	mso-list-type:hybrid;
	mso-list-template-ids:-2105479504 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l12:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:1682660849;
	mso-list-type:hybrid;
	mso-list-template-ids:1556518110 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14
	{mso-list-id:1816024000;
	mso-list-type:hybrid;
	mso-list-template-ids:-1950839336 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l15
	{mso-list-id:1881089785;
	mso-list-type:hybrid;
	mso-list-template-ids:-769523296 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l15:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l16
	{mso-list-id:1937866530;
	mso-list-type:hybrid;
	mso-list-template-ids:190511004 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Tabla normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
table.MsoTableGrid
	{mso-style-name:"Tabla con cuadr\00EDcula";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=ES-TRAD link=blue vlink=purple style='tab-interval:35.4pt'>

<div class=WordSection1>

<p class=MsoNormal align=center style='text-align:center;tab-stops:145.3pt center 261.5pt'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:16.0pt;
mso-bidi-font-size:12.0pt'>TEMA 27<o:p></o:p></span></u></b></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt;mso-list:l12 level1 lfo1'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>ANOMALÍAS CONGÉNITAS DEL
TIROIDES<o:p></o:p></span></b></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l14 level1 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>AGENESIA TIROIDEA</u>: ausencia de tiroides
por falta de formación.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l14 level1 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>QUISTE DEL CONDUCTO TIROGLOSO</u>:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14 level2 lfo2'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Tumor
quístico de la línea anterior del cuello. Al pincharlo, contiene un liquido
mucoide (color parado oscuro). Pasado el tiempo vuelve a rellenarse (recidiva),
por lo que es necesaria la extirpación quirúrgica.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14 level2 lfo2'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Etiología:
persistencia de restos del conducto tirogloso (forma un quiste por secreción de
las células epiteliales, normalmente a la altura del hioides).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14 level2 lfo2'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Es
una cavidad revestida de epitelio (quiste); por fuera puede haber folículos
tiroideos.</p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l14 level1 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>TIROIDES ECTÓPICO</u>: tejido tiroideo fuera
de la glándula tiroides (en la glándula, en la zona de la V lingual o en el
trayecto del conducto tirogloso).</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l12 level1 lfo1'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>TIROIDITIS<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Inflamación
del tejido tiroideo. Hay 4 tipos:</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l15 level1 lfo3'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'>TIROIDITIS
DE HASHIMOTO: <o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Etiología</u>:
autoinmune, frecuente en mujeres.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level3 lfo3'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><u>Ac</u>:
en la mayoría hay anticuerpos antiperoxidasa tiroidea en suero.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Clínica</u>:
suele cursar con hipotiroidismo (y a veces bocio), pero no esta indicada la
cirugía si el bocio no es compresivo.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Macro</u>:
el tiroides es grisáceo, con muchos nódulos, consistencia blanda (recuerda a un
ganglio linfático).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Micro</u>:
destrucción de folículos tiroideos (sustituidos por tejido linfoide maduro, con
muchos folículos linfoides con centro germinativo y periferia con células
plasmáticas). Transformación oncocítica del epitelio de los folículos.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l15 level1 lfo3'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'>TIROIDITIS
SUBAGUDA LINFOCITARIA INDOLORA:<o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Etiología</u>:
autoinmune, frecuente en mujeres tras el parto, y adultos de edad media.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level3 lfo3'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><u>Ac</u>:
anticuerpos antitiroideos (por lo que se considera variante de Hashimoto).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Clínica</u>:
tumefacción no dolorosa del tiroides, e hipertiroidismo (<span
style='mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria'>&#8800;</span>
Hashimoto).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Micro</u>:
destrucción folicular focal con infiltrados linfocitarios.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Evolución</u>:
en la mayoría cura (no progresa a tiroiditis crónica); 1/3 de los pacientes
evolucionan a hipotiroidismo.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l15 level1 lfo3'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'>TIROIDITIS
AGUDA GRANULOMATOSA DE QUERVAIN:<o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Etiología</u>:
viral (suele precederse de una infección respiratoria, mujeres de edad media.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Clínica</u>:
tumefacción dolorosa (en parte anterior del cuello), fiebre, astenia, mialgias.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Micro</u>:
destrucción del epitelio folicular, rodeado primero de PMN y luego de
macrófagos y CGM, formando granulomas alrededor de los folículos destruidos.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Evolución</u>:
cura en un par de meses.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l15 level1 lfo3'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'>TIROIDITIS
DE RIEDEL:<o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Etiología</u>:
inflamación crónica fibrosante del tiroides de etiología desconocida (sugiere
relación con una proliferación fibromatosa del tejido conjuntivo, ya que esa
fibrosis ocurre en otros tejidos). Típico de adultos (más frecuente en mujeres)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Clínica</u>:
masa dura, no dolorosa, en zona tiroidea (en casos avanzados, hipotiroidismo).
Si la inflamación crónica fibrosante se extiende, provoca disfagia, disfonía y
disnea.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Macro</u>:
tiroides aumentado de tamaño y fibroso, muy adherido a tejidos adyacentes.</p>

<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;mso-add-space:auto;
text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l15 level2 lfo3'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>Micro</u>:
destrucción de folículos tiroideos (sustituidos por tejido fibroso denso).</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=133 valign=top style='width:132.5pt;border:solid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b
  style='mso-bidi-font-weight:normal'>HASHIMOTO<o:p></o:p></b></p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border:solid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b
  style='mso-bidi-font-weight:normal'>SUBAGUDA LINFOCIT.<o:p></o:p></b></p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border:solid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b
  style='mso-bidi-font-weight:normal'>AGUDA GRANULOMT.<o:p></o:p></b></p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border:solid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b
  style='mso-bidi-font-weight:normal'>RIEDEL<o:p></o:p></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=133 valign=top style='width:132.5pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Autoinmune: Ac
  antipx.</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Autoinmune: Ac
  antitir.</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Viral (tras infecc)</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Desconocida
  (fibrosa)</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=133 valign=top style='width:132.5pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Mujeres 7:1</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Mujeres postparto</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Mujeres EM</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Adultos
  (&gt;mujeres 4:1)</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=133 valign=top style='width:132.5pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Hipotiroidismo
  (bocio)</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>NO DOLOR.
  Hiper&gt;Hipo</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>SI DOLOR</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>NO DOLOR (hipo)</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td width=133 valign=top style='width:132.5pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Destrucción =
  TEJIDO LINFOIDE</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Destrucción
  folículos = INFILTRADO LINF.</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Destrucción
  epitelio = GRANULOMAS</p>
  </td>
  <td width=133 valign=top style='width:132.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>Destrucción =
  TEJIDO FIBROSO DENSO</p>
  </td>
 </tr>
</table>

<p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l12 level1 lfo1'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>ENFERMEDAD DE GRAVES<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Hiperplasia
difusa del tiroides, afecta a adultos jóvenes (más a hombres 5:1).</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l16 level1 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>Clínica</u>: hipertiroidismo, oftalmopatía
infiltrativa (exoftalmos y retracción palpebral) y dermatopatía infiltrativa
(mixedema pretibial). Suele provocar también bocio.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l16 level1 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>Etiología</u>: autoinmune, por deficiente
función de L<sub>T</sub> supresores (permiten proliferación excesiva de L<sub>Th</sub>,
estimulando a linfocitos B, que producen Ac, que provocan:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16 level2 lfo4'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Al
unirse a las células foliculares, estimulan su función y el crecimiento
tiroideo.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16 level2 lfo4'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Al
unirse a fibroblastos perioculares, provocan que sinteticen colágeno,
provocando retracción palpebral.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16 level2 lfo4'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Facilitan
acumulo de MPS retroorbitarios, facilitando la protrusión ocular (exoftalmos).</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l16 level1 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>Morfología</u>: tiroides grande y de
consistencia aumentada, y color pálido. Los folículos tienen:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16 level2 lfo4'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Epitelio
hiperplásico y células altas de núcleos pseudoestratificados.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16 level2 lfo4'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Coloide
pálido con vacuolas de tipo reabsortivo.</p>

<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;mso-add-space:auto;
text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l16 level2 lfo4'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Puede
haber infiltrado linfoplasmocitario en el intersticio interfolicular y en
tejidos perioculares.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l12 level1 lfo1'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>CARCINOMA PAPILAR DE
TIROIDES<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Tumor
epitelial maligno, derivado del epitelio folicular. Es el más frecuente (75% de
neoplasias de tiroides). Afecta a adultos (30-40 años), más a mujeres 3:1, y se
asocian a radiaciones ionizantes.</p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level1 lfo5'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>Clínica</u>: podemos detectar:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Solo
el nódulo tiroideo (carcinoma)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Nódulo
tiroideo + ganglio cervical aumentado (por metástasis linfática)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Solo
el ganglio metastásico cervical (sin palpar lesión en el tiroides)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level1 lfo5'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>Macro</u>: puede ser nodular, quístico,
esclerosante focal o esclerosante difuso.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level1 lfo5'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>Micro</u>: </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Las
células tienen sus NUCLEOS EN VIDRIO ESMERILADO: irregulares, con una membrana
nítida y contenido claro (aspecto esmerilado), con pseudoinclusiones en su
interior.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Presencia
de cuerpos de psammoma (concreciones calcáreas concéntricas).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Al
ser PAPILAR, las células se disponen formando papilas (estructuras digitiformes
con un eje conjuntivo central y capas de células epiteliales alrededor).
VARIANTES:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:90.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level3 lfo5'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>FOLICULAR:
las células se disponen formando folículos de aspecto oncocítico (carcinoma
papilar con patrón folicular o folicular oncocítico). Mejor pronostico.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:90.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level3 lfo5'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>ESCLEROSANTE:
además de áreas papilares y solidas, hay intensa reacción desmoplástica que
afecta a la glándula tiroidea. Asociado a metástasis ganglionares.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:90.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level3 lfo5'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>MICROPAPILAR:
papilas muy pequeñas (&lt;1cm) detectadas en el estudio de tiroides extirpado
por otras patologías (Graves, Hashimoto).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level1 lfo5'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>Evolución</u>: se clasifican en estadios:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Estadio
I: tumor solo en tiroides (supervivencia a 5 años: 98%).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Estadio
II: metástasis ganglionares en ganglios del cuello (supervivencia 98%: no
empeora el pronostico). Como hemos visto, a veces las metástasis son la primera
manifestación.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Estadio
III: infiltra tejidos blandos del cuello (supervivencia 70%).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6 level2 lfo5'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Estadio
IV: metástasis hematógenas a distancia (la supervivencia cae).</p>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l6 level1 lfo5'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>Tratamiento</u>: quirúrgico (tiroidectomía
total), ya que muchas veces el tumor es multicéntrico.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><span
style='font-family:Webdings'>ii</span> No confundir el carcinoma papilar con
patrón folicular, con el carcinoma folicular de tiroides.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l12 level1 lfo1'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>CARCINOMA FOLICULAR DE
TIROIDES<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Carcinoma
de tiroides poco frecuentes (no más de 15-20%). Forma folículos, pero el núcleo
de sus células no es en vidrio esmerilado como en el carcinoma papilar.</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l9 level1 lfo6'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Para el diagnostico se requieren criterios
histológicos: invasión de la capsula y/o presencia de permeación neoplásica
intravascular.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l9 level1 lfo6'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Macro: hay dos variantes:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l9 level2 lfo6'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Mínimamente
invasivo: igual que un adenoma folicular, pero además hay invasión de la
capsula o vasos de la capsula (o ambos).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l9 level2 lfo6'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Ampliamente
invasivo: la neoplasia penetra en el tejido tiroideo adyacente.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l9 level1 lfo6'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Micro: tumor formado por folículos (parecido al
adenoma folicular), pero al buscar minuciosamente, encontramos que la capsula
de tejido conjuntivo que le rodea está rebasada, o bien que nidos de folículos
están en la luz de vasos de la capsula.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l9 level1 lfo6'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Suele diseminar vía hemática (metástasis a
hígado, pulmón y hueso). Supervivencia del 70% en el mínimamente invasivo, y
sólo un 30% en el ampliamente invasivo.</p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l9 level1 lfo6'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Tratamiento: quirúrgico (extirpación del
hemitiroides + I<sup>131</sup>).</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l12 level1 lfo1'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>TUMOR DE CÉLULAS DE HÜRTLE<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Tumor
tiroideo formado por oncocitos (células de citoplasma amplio, acidófilo y
granular que contienen gran cantidad de megamitocondrias), que puede
corresponder a un carcinoma papilar o folicular:</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Primero, fijarnos en los <u>núcleos</u> de las
células:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5 level2 lfo7'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Si
son en vidrio esmerilado: <i style='mso-bidi-font-style:normal'>carcinoma
papilar de células de Hürtle</i>.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5 level2 lfo7'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Si
no, valorar <u>criterios de infiltración</u>:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5 level3 lfo7'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Si
infiltra capsula o vasos capsulares: <i style='mso-bidi-font-style:normal'>carcinoma
folicular de células de Hürtle</i>.</p>

<p class=MsoListParagraphCxSpLast style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5 level3 lfo7'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Si
no infiltra: <i style='mso-bidi-font-style:normal'>adenoma de células de Hürtle</i>.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l12 level1 lfo1'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>CARCINOMA MEDULAR DE TIROIDES<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Tumor
tiroideo derivado de las células parafoliculares (secretoras de calcitonina).</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Puede ser esporádico o familiar (20% de los
casos, autosómico dominante).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5 level2 lfo7'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Si
es familiar, puede ser solitario o asociado a una NEM (NEM-2a o NEM-2b).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5 level2 lfo7'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>En
las formas familiares hay mutación del oncogén ret, lo que se usa para su
diagnostico y para screening familiar.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Macro: tumor único (o múltiple en formas
familiares), blanquecino, de consistencia firme pero mal delimitado al
parénquima adyacente.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Micro: formado por celulas poligonales, de
aspecto inocente, sin atipias ni mitosis.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5 level2 lfo7'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Inmunohistoquímica:
positividad para cromogranina y calcitonina.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5 level2 lfo7'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>En
el estroma tumoral hay depósitos de sustancia amiloide derivados de péptidos
modificados de calcitonina.</p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>La neoplasia infiltra estructuras del cuello, y
da metástasis linfáticas y hemáticas.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:145.3pt center 261.5pt'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:16.0pt;
mso-bidi-font-size:12.0pt'>TEMA 28<o:p></o:p></span></u></b></p>

<p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l8 level1 lfo8'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>SÍNDROME DE CUSHING<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Síndrome
con hiperfunción cortical con hipersecreción de cortisol.</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l7 level1 lfo9'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Clínica: cara de luna llena con obesidad troncular;
atrofia cutánea y muscular con osteoporosis, debilidad, hirsutismo,
intolerancia a la glucosa, encefalopatía, inmunodepresión e infecciones.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l7 level1 lfo9'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>AP: la morfología de la corteza suprarrenal
varía según la etiología:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level2 lfo9'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><i
style='mso-bidi-font-style:normal'><u>Iatrogénica</u></i> (administración
prolongada de corticoides): atrofia bilateral.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level2 lfo9'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><i
style='mso-bidi-font-style:normal'><u>Adenoma basófilo o hiperplasia
hipofisaria</u></i>: hiperplasia bilateral.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level2 lfo9'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><i
style='mso-bidi-font-style:normal'><u>Secreción ectópica de ACTH</u></i>:
hiperplasia</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level2 lfo9'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><i
style='mso-bidi-font-style:normal'><u>Lesión cortical</u></i>: hiperplasia,
adenoma o carcinoma unilateral. Si es funcionante, hay atrofia contralateral (puede
no ser funcionante).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level3 lfo9'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><u>Hiperplasia
cortical</u>: hiperplasia bilateral y secundaria a un aumento de ACTH.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level4 lfo9'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hay aumento de las capas reticular y
fasciculada, con engrosamiento difuso de la corteza.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level4 lfo9'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Variante: hiperplasia micronodular pigmentada
(en niños, no relacionada con ACTH; células con pigmentos tipo melanina).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level3 lfo9'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><u>Adenoma
cortical</u>: tumor único, bien definido, amarillento. Corteza adyacente y
contralateral atróficas.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level4 lfo9'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Formado por células grandes, microvacuoladas,
sin atipias ni mitosis.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level3 lfo9'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><u>Carcinoma
cortical</u>: tumor grande, no encapsulado, infiltra el retroperitoneo.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level4 lfo9'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Células grandes, con altas atipias y mitosis. </p>

<p class=MsoListParagraphCxSpLast style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7 level4 lfo9'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hay áreas de necrosis y hemorragia.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l8 level1 lfo8'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>HIPERALDOSTERONISMO<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Primario:
</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l0 level1 lfo10'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>70% Adenoma cortical con hipersecreción de
aldosterona (síndrome de Conn). Los adenomas son tumores pequeños, solitarios,
y sus celulas se parecen a las de la capa fasciculada cortical.</p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l0 level1 lfo10'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>30% Hiperplasia cortical. El carcinoma secretor
de aldosterona es muy poco frecuente.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Secundario:
por activación del sistema renina-angiotensina, que se produce por:</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l13 level1 lfo11'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Isquemia renal, o estados de edema crónico.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l13 level1 lfo11'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Tumores productores de reninaToma de
anticonceptivos, diabetes insípida y síndrome de Bartier (hiperplasia de
celulas del aparato yuxtaglomerular).</p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l13 level1 lfo11'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>En el hiperaldosteronismo secundario la morfología
de las suprarrenales suele ser normal.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l8 level1 lfo8'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>SISTEMA SIMPÁTICO-ADRENAL<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Es
un sistema neuroendocrino que se encarga de la secreción de catecolaminas para
actuar en zonas desinervadas de forma duradera. Derivan de las células
primitivas de la cresta neural, dando:</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l4 level1 lfo12'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>M2: se quedan en los ganglios simpáticos.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l4 level1 lfo12'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>M1: maduran a neuronas (dando neuroblastomas)</p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l4 level1 lfo12'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>M3: maduran a células cromafines (dando
feocromocitomas).</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Está
formado por:</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l1 level1 lfo13'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Sistema nervioso simpático</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l1 level1 lfo13'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Medula suprarrenal: parte central de la glándula,
formada por células cromafines (ya que se tiñen de color pardo con la reacción
cromafín, lo que evidencia que hay catecolaminas) y una red vascular capilar
alrededor. </p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l1 level1 lfo13'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Paraganglios cromafines: situados a ambos lados
de la columna, crecen hasta los 3 años y luego involucionan. Formador por
células cromafines y células ganglionares. </p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Las
neoplasias más frecuentes dependen de la edad:</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l11 level1 lfo14'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Infancia: estirpe neural (neuroblastoma,
ganglioneuroblastoma y ganglioneuroma)</p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l11 level1 lfo14'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Adulto: células cromafines (hiperplasia medular
suprarrenal y feocromocitoma).</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l3 level1 lfo15'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'><u>TUMORES
NEURALES</u></i>: son los 4º tumores más frecuentes en niños. Pueden situarse
en cualquier parte del SNS, pero sobre todo en abdomen (suprarrenal y ganglios
paravertebrales). Micro: blancos, voluminosos, blandos con áreas de hemorragia,
necrosis y calcificación.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level2 lfo15'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>NEUROBLASTOMA</u>:
tumor muy indiferenciado, en que las células están alrededor de un espacio
central claro, formando SEUDORROSETAS DE HOMER-WRIGHT (formadas de
prolongaciones fibrilares de las células). Hay distintos factores pronósticos:</p>

<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;mso-add-space:auto;
text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=265 valign=top style='width:265.0pt;border:solid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>FAVORABLE</p>
  </td>
  <td width=265 valign=top style='width:265.0pt;border:solid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>DESFAVORABLE</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1;mso-yfti-lastrow:yes'>
  <td width=265 valign=top style='width:265.0pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Edad
  &lt;18 meses</p>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Tumor
  localizado (sin metástasis)</p>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Diferenciación
  a ganglioneuroma/céls. Schwann</p>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>No
  alteraciones cromosómicas/telomerasas</p>
  </td>
  <td width=265 valign=top style='width:265.0pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Edad
  &gt;18 meses</p>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Tumor
  no resecable, metástasis (gangl/linf)</p>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>No
  células ganglionares ni céls. Schwann</p>
  <p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Alteraciones
  cromosómicas</p>
  </td>
 </tr>
</table>

<p class=MsoListParagraphCxSpFirst style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level2 lfo15'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>GANGLIONEUROBLASTOMAS</u>:
tumores neuronales con diferenciación a células ganglionares (núcleo mas
grande, y sustancia de Nissl = gránulos basófilos en citoplasma). También
aparecen células de Schwann.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level3 lfo15'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Grado
histológico: depende de:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level4 lfo15'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Capacidad de los neuroblastos primitivos para
diferenciarse en células ganglionares.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level4 lfo15'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cantidad de material eosinófilo neurofibrilar </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level3 lfo15'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Los
neuroblastomas y ganglioneuroblastomas pueden madurar o sufrir regresión
espontanea.</p>

<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;mso-add-space:auto;
text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l3 level2 lfo15'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>GANGLIONEUROMA</u>:
tumor benigno poco frecuente, típico de niños. Son bien delimitados y
blanquecinos, formados por células ganglionares y células de Schwann (lo aunque
hay zonas sin células ganglionares que pueden confundirse con un neurofibroma).</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l3 level1 lfo15'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'><u>TUMORES
DE CÉLULAS CROMAFINES</u></i>: tienen excesiva producción de catecolaminas,
puede ser continua (dan HTA mantenida) o discontinua (HTA paroxística).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level2 lfo15'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>HIPERPLASIA
MEDULAR SUPRARRENAL</u>: hablamos de ella cuando la glándula es macroscópicamente
normal, pero con aumento de tamaño (difuso o nodular).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level3 lfo15'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Cuando
la hiperplasia es multinodular hay que hacer DD con el feocromocitoma, según el
tamaño: &lt;1cm diámetro hiperplasia medular; &gt;1cm feocromocitoma.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level2 lfo15'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><u>FEOCROMOCITOMA</u>:
paraganglioma (ya que sus células son afines al dicromato, y también a la
reacción cromafín). Pueden ser esporádicos o familiares (NEM, etc.).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level3 lfo15'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Tumor
del 10%: el 10% son extrasuprarrenales, bilaterales, malignos.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level3 lfo15'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Macro:
bien delimitado, encapsulado con gran vascularización. Si es grande, tiene
degeneración isquémica (necrosis, hemorragia) en el centro.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level3 lfo15'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Micro:
células son eosinófilas, con muchos capilares alrededor. Pueden tener:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level4 lfo15'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pseudoinclusiones celulares y glóbulos hialinos
intracitoplasmáticos (PAS+ y diastasa resistentes).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level4 lfo15'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Abundantes vacuolas lipídicas degenerativas que
simulan tumores corticales (hay que hacer inmunohistoquímica con enolasa
neuronal especifica y cromogranina para diferenciarlos).</p>

<p class=MsoListParagraphCxSpLast style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3 level3 lfo15'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Hay
distinto grado de atipia, y no suele haber mitosis. Aun así, el grado de atipia
no es predictivo del comportamiento biológico. Los únicos criterios seguros de
malignidad son las metástasis.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l8 level1 lfo8'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>PÁNCREAS ENDOCRINO<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>El
páncreas endocrino está formado por los islotes de Langerhans, que contiene
distintos tipos celulares que se identifican con inmunohistoquímica (células
beta, alfa, delta). Los tumores derivados de ellos cursan con producción de
hormonas y se asocian a otros tumores endocrinos. Pueden ser adenomas y
carcinomas, pero la hiperplasia de islotes provoca una clínica parecida.</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l10 level1 lfo16'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>ADENOMA</u>: tumor bien delimitado, blando y
rojizo (muy vascularizado).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level2 lfo16'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Micro:
cordones y lóbulos de células epiteliales con estroma muy vascularizado
alrededor. Secretan hormonas (demostrables por inmunohistoquímica): pueden ser
insulinomas, glucagonomas, gastrinomas</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level2 lfo16'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Clínica:
puede ser por:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level3 lfo16'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Compresión:
del drenaje pancreático o de estructuras vecinas (colon).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level3 lfo16'><![if !supportLists]><span style='font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span
style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Secreción
de hormonas, dando:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level4 lfo16'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hiperinsulinismo (da crisis hipoglucémicas con
trastornos psíquicos).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level4 lfo16'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Síndrome de Zollinger-Ellison: ulceras por
hipersecreción de gastrina.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level4 lfo16'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>NEM-I: con lesiones hipofisarias, paratiroideas
e islotes. Dan hiperparatiroidismo.</p>

<p class=MsoListParagraphCxSpLast style='margin-left:144.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level4 lfo16'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Otros cuadros por producción de glucagón, VIP
(diarrea con hipopotasemia), somatostatina, serotonina</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l10 level1 lfo16'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>HIPERPLASIA DE ISLOTES</u>: hay dos tipos:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level2 lfo16'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>DIFUSA:
presencia de islotes gigantes en recién nacidos hijos de diabéticas.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10 level2 lfo16'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>NODULAR:
presencia de nódulos similares a adenomas (debe de haber solo uno, si hay varios
no se trataría de adenomas sino de hiperplasia adenomatosa).</p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l10 level1 lfo16'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>CARCINOMA</u>: solo se distingue del adenoma
por la presencia de metástasis.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l8 level1 lfo8'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt'>NEOPLASIAS ENDOCRINAS
MÚLTIPLES (NEM)<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'>Grupo
de síndromes familiares (con herencia dominante) que pueden afectar a la vez a
varios órganos endocrinos. Hay distintos tipos:</p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-justify:inter-ideograph;
text-indent:-18.0pt;mso-list:l2 level1 lfo17'><![if !supportLists]><span
lang=EN-US style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-ansi-language:EN-US'><span style='mso-list:Ignore'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><u><span
lang=EN-US style='mso-ansi-language:EN-US'>NEM-I (SÍNDROME DE WERMER)<o:p></o:p></span></u></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Poco
frecuente, por mutación del gen supresor MEN-1.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Afecta
a 3 glándulas: <i style='mso-bidi-font-style:normal'>paratiroides</i> (adenoma
o hiperplasia), <i style='mso-bidi-font-style:normal'>hipófisis</i> (adenoma o
hiperplasia, frecuentemente prolactinoma) e <i style='mso-bidi-font-style:normal'>islotes
de Langerhans</i> (adenoma, hiperplasia o carcinoma). Ademas, suele asociar
hiperplasia de corteza suprarrenal.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Clínica:
alteraciones hormonales diversas, pero siempre da hiperparatiroidismo. También
puede comprimir o dar clínica hormonal (glucagón, VIP, somatostatina).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Las
hiperplasias suelen ser nodulares (con nódulos múltiples), siendo hiperplasias
adenomatosas (ya que los adenomas son únicos). </p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo17'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>NEM-IIa (SÍNDROME DE SIPPLE)<o:p></o:p></u></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Por
mutación del protooncogen ret del cromosoma 10, en la línea germinal.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Produce
<i style='mso-bidi-font-style:normal'>feocromocitoma, hiperplasia paratiroidea
y carcinoma medular de tiroides</i> (que se asocia a hiperplasia de células C
secretoras de calcitonina).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Dx:
hacer estudio genético familiar (protooncogen RET), estudio de calcitonina
(aumentado en familiares afectos).</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>El
carcinoma tiroideo suele ser multicéntrico, el feocromocitoma bilateral, y el
paratiroides suele producir hiperparatiroidismo.</p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo17'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><u>NEM-IIb:<o:p></o:p></u></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Por
mutación del protooncogen RET del cromosoma 10, pero distinta a NEM-IIa.</p>

<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;mso-add-space:auto;
text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l2 level2 lfo17'><![if !supportLists]><span style='font-family:"Courier New";
mso-fareast-font-family:"Courier New"'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]>Igual
que NEM-IIa, pero <i style='mso-bidi-font-style:normal'>sin hiperparatiroidismo</i>
y <i style='mso-bidi-font-style:normal'>con ganglioneuromas mucocutáneos</i> y <i
style='mso-bidi-font-style:normal'>habito marfanoide</i>.</p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph'><o:p>&nbsp;</o:p></p>

</div>

</body>

</html>
